The challenges and benefits of cardiovascular risk assessment in clinical practice

Steven A Grover1, Ilka Lowensteyn

  • 1McGill Cardiovascular Health Improvement Program, Montreal, Québec, Canada. steven.grover@mcgill.ca

Insights

Cardiovascular risk assessment helps identify individuals needing hypertension and dyslipidemia management. This review evaluates risk engines and proposes strategies to improve their clinical use for better patient outcomes.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Health Informatics

Background:

  • Expert guidelines recommend cardiovascular risk assessment for hypertension and dyslipidemia.
  • Risk assessment identifies individuals benefiting most from risk factor management.
  • Current use of cardiovascular risk assessment in practice is suboptimal.

Purpose of the Study:

  • To review the strengths and weaknesses of available cardiovascular risk assessment tools.
  • To propose an evidence-based approach for maximizing the clinical impact of risk assessment.
  • To guide clinicians in utilizing risk assessment effectively for patient care.

Main Methods:

  • Systematic review of current cardiovascular risk engines.
  • Analysis of evidence supporting the clinical utility of risk assessment.
  • Development of a practical approach for integrating risk assessment into practice.

Main Results:

  • Existing risk engines have varying strengths and limitations.
  • Risk assessment can reassure low-risk patients and motivate high-risk patients.
  • Effective implementation strategies are needed to increase the uptake of risk assessment.

Conclusions:

  • Cardiovascular risk assessment is a valuable tool for managing hypertension and dyslipidemia.
  • Addressing barriers to its use is crucial for improving patient outcomes.
  • A structured approach can enhance the clinical impact of risk assessment.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...